Companies
Companies
Breaking Barriers in Gene Therapy: Insights from Viralgen’s Head of Regulatory Affairs
🎙️ In this podcast episode, María Orío from Viralgen tackles gene therapy challenges and innovative solutions. 🧬🧪🔬💼
French Parliamentarians Fight to Ban Cell-Based Meat!
French parliamentarians have proposed a bill to ban cell-based meat, aiming to protect the traditional meat industry and French food culture. 🇫🇷🥩🍔📑🌍
Merck Teams Up with C4T to Revolutionize Cancer Treatment
🔍 Merck teams up with C4 Therapeutics to revolutionize treatment options using degrader-antibody conjugate technology. 💪🔬💉 Innovation Oncology
Aldevron’s Mega Expansion in Minnesota: Revolutionizing Gene-Based Treatments!
🏢🔬 Aldevron seeks city approval for Minnesota expansion to produce genetic vaccines and therapies. 💉💊 Investment of $30 million, hundreds of jobs created. 📈
Boehringer Ingelheim: Mastering Microbial Tech for Biotech Success
🔬 Discover how Boehringer Ingelheim's microbial technology expertise turns biologic innovation into commercial success. 🌍💼 BiotechLeaders
Pfizer’s $43bn Seagen Deal Boosts Cancer Portfolio
📢 Pfizer seals the deal with Seagen, bolstering its presence in the cancer drug market. 💪✨ $43bn acquisition expands Pfizer's cancer treatment portfolio.
AstraZeneca Boosts Vaccine Portfolio with $11bn Icosavax Deal
🔍 AstraZeneca acquires Icosavax for $1.1bn, expanding its respiratory vaccine pipeline and strengthening its global biotech position. 🌡️💉🌍
Vandria SA Raises CHF18m for Neurodegenerative Disease Treatment
📣 Vandria SA 🏢 secures CHF18m 💰 in Series A financing 💼 to develop VNA-318, a potential treatment for neurodegenerative diseases.
Antabio SAS Raises €25m for Breakthrough Antibiotic Development
📢 Antibiotics specialist Antabio SAS has secured €25m in Series B financing to support clinical development of next-gen antibacterial combination. 🧪🔬
Germany’s Block on NGT Deregulation Sparks Controversy
📅 At the EU Council, ministers failed to adopt new regulation on genomic techniques. 🌱 Spain pushed, ❌ Germany opposed. 🌾 Debate: NGT breeds vs organic breeds and patent bans.
